eISSN: 1994-4624 / ISSN: 1813-176x
Register
Login
International Journal of Molecular Medicine and Advance Sciences
2006, Volume 2, Issue 2 : 138-143 doi: ijmmas.2006.138.143
Research Article
Protective Role of Antigens from Peritoneal Exudates of Infected Mice Against Toxoplasmosis
Published
Dec. 30, 2005
Abstract

"<I>Toxoplasma gondii </I>is an obligate intracellular parasite that infects all mammalian cells. Several
antigens such as excreted/secreted antigens have been identified as potential vaccine candidates. The main
goal of the present study was to determine how excreted/secreted antigens from peritoneal exudates of infected
mice (mESA) stimulate cell-mediated immune responses and protective immunity against toxoplasmosis in the
murine model. The supernatants produced from the peritoneal fluids were fractionated by precipitation with
ammonium sulphate solution (30-80% saturated). For induction of cell-mediated immune responses, Delayed
type hypersensitivity was measured in injected footpad measured in injected footpad. By adding [ H] thymidine
to cell cultures, their radioactivities were measured. Nitric oxide was measured by Griess method. For
immunization, Balb/c mice were immunized 2 times with mESA, mESA-40% and Toxoplasma Lysate Antigen
(TLA). The virulent RH strain of <I>Toxoplasma gondii </I>was used for challenging. The pattern of lymphocyte
responsiveness was dependent on the kind of antigen employed for induction of the blastogenesis. In
sensitized mice, those received mESA-40% displayed higher counts per minute than mice that stimulated by
mESA (p&lt;0.05). The highest amounts of nitric oxide were observed in macrophages, which received mESA-40%
and mESA (p&lt;0.05). Mice immunized with mESA-40% survived longer than those immunized with mESA and
other antigens (p&lt;0.05). As fraction 40% (mESA-40%) showed a good result in induction of cell-mediated
responses in the murine model, for getting better response, this antigen have to be purified further."

Keywords
License
Copyright (c) International Journal of Molecular Medicine and Advance Sciences
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
Int. J. Mol. Med. Adv. Sci. open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Recommended Articles
Predictors of Acute Coronary Syndrome Outcomes: A Multicenter Evaluation of Clinical, Biochemical, and Demographic Risk Factors
11-15
Internet of Medical Things in Healthcare Delivery: Transforming Modern Healthcare Through Connected Technologies
1-6
Healthcare Disparities and Equity in Medical Services: Challenges, Determinants, and Strategies for Achieving Equitable Healthcare
27-34
Wearable Devices for Chronic Disease Monitoring: Transforming Healthcare Through Continuous Digital Health Surveillance
22-26
International Journal of Molecular Medicine and Advance Sciences
+447480266638
+447480266638
support@ijmmas.com
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives (CC BY-NC-ND) license. Open Access Publication.
Copyright © ©International Journal of Molecular Medicine and Advance Sciences. All rights reserved.